Characteristics | Baseline(nā= 64) | Baseline for patients with follow-up (nā= 52) |
---|---|---|
Male: Female (n) | 22:42 | 16:36 |
Age of onset (years-old) | 11.4(6.4,13.9) | 11.8(6.0,14.0) |
Time from onset to diagnosis (years) | 0.9(0.5,2.3) | 0.8(0.5,2.3) |
Number of organs involved in the course of the disease | ||
āmRSS | 12.0(8.0,17.0) | 12.0(8.0,16.0) |
āRaynaud's phenomenon | 48/64(75.0%) | 38/52(73.1%) |
āRespiratory system | 44/64(68.8%) | 36/52(69.2%) |
āJoint system | 36/64(56.3%) | 30/52(57.7%) |
āDigestive system | 23/64(35.9%) | 20/52(38.5%) |
āHaematological system | 18/63(28.6%) | 15/52(28.8%) |
āMusculoskeletal System | 13/64(20.3%) | 10/52(19.2%) |
āCardiovascular System | 11/63(17.5%) | 11/51(21.6%) |
āNervous System | 5/64(7.8%) | 4/52(7.7%) |
āUrinary System | 1/64(1.6%) | 1/52(1.9%) |
Laboratory tests at baseline | ||
āElevated CRP | 16/53(30.2%) | 13/43(30.2%) |
āElevated ESR | 16/59(27.1%) | 13/48(27.1%) |
āAnaemia | 6/62(9.7%) | 5/51(9.8%) |
āAbnormal liver function | 16/62(25.8%) | 14/51(27.5%) |
āHypoalbuminaemia | 12/53(22.6%) | 9/45(20.0%) |
āHypocomplementemia | 14/57(24.6%) | 12/46(26.1%) |
āPositive anti-Scl-70 antibodies | 36/64(56.3%) | 29/52(55.8%) |
āPresence of ā„ā2 autoantibodies | 46/64(71.9%) | 38/52(73.1%) |